TransCode Therapeutics Incの株価・株式情報
企業概要
TransCode Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for treating metastatic disease. Co.'s lead therapeutic candidate, TTX-MC138, is an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive.
